UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Nature communications, 2018-03, Vol.9 (1), p.896-10, Article 896

2018

Volltextzugriff (PDF)

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

Journal of clinical oncology, 2012-05, Vol.30 (15), p.1879-1887

2012

Volltextzugriff (PDF)

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

The lancet oncology, 2010-03, Vol.11 (3), p.231-240

2010

Volltextzugriff (PDF)

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Nature communications, 2023-07, Vol.14 (1), p.4017-4017, Article 4017

2023

Volltextzugriff (PDF)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The lancet oncology, 2017-07, Vol.18 (7), p.929-945

2017

Volltextzugriff (PDF)

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Health technology assessment (Winchester, England), 2023-11, Vol.27 (25), p.1-176

2023

Volltextzugriff (PDF)

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

The lancet oncology, 2007-02, Vol.8 (2), p.119-127

2007

Volltextzugriff (PDF)

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study

Breast cancer research : BCR, 2022-09, Vol.24 (1), p.61-61, Article 61

2022

Volltextzugriff (PDF)

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Breast cancer research : BCR, 2023-04, Vol.25 (1), p.39-39, Article 39

2023

Volltextzugriff (PDF)

Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients

Breast cancer research : BCR, 2019-12, Vol.22 (1), p.2-20, Article 2

2019

Volltextzugriff (PDF)

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Volltextzugriff (PDF)

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA

Nature communications, 2021-07, Vol.12 (1), p.4479-4479, Article 4479

2021

Volltextzugriff (PDF)

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R46-R46, Article R46

2012

Volltextzugriff (PDF)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10099), p.1048-1060

2017

Volltextzugriff (PDF)

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

NPJ breast cancer, 2021-02, Vol.7 (1), p.11-11, Article 11

2021

Volltextzugriff (PDF)

In Regard to Vaidya et al

International journal of radiation oncology, biology, physics, 2015-08, Vol.92 (5), p.954-955

2015

Volltextzugriff (PDF)

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-05, Vol.327 (20), p.1963

2022

Volltextzugriff (PDF)

Implementation of platform trials in the COVID-19 pandemic: A rapid review

Contemporary clinical trials, 2022-01, Vol.112, p.106625-106625, Article 106625

2022

Volltextzugriff (PDF)

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

Journal of clinical oncology, 2021-08, Vol.39 (24), p.2720-2731

2021

Volltextzugriff (PDF)

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Journal of clinical oncology, 2022-01, Vol.40 (3), p.282-293

2022

Volltextzugriff (PDF)

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Radiotherapy and oncology, 2016-07, Vol.120 (1), p.114-118

2016

Volltextzugriff (PDF)

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1752-1752

2024

Volltextzugriff (PDF)

TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)

European thyroid journal, 2017-07, Vol.6 (4), p.197-207

2017

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCurrent Controlled Trials In Cardiovascular Medicine

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(145)

Sprache

Englisch
(145)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

In Regard to Vaidya et al

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

Implementation of platform trials in the COVID-19 pandemic: A rapid review

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply

TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)

Aktive Filter

Suchergebnisse filtern